{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:46:26Z","timestamp":1786988786520,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,17]],"date-time":"2026-12-17T00:00:00Z","timestamp":1797465600000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["R01AR076973"],"award-info":[{"award-number":["R01AR076973"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eprac.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:07:31Z","timestamp":1753484851000},"page":"1592-1600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis and Management of Hypophosphatemic Disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Eva S.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.07.015_bib1","series-title":"Calcium, phosphate, and magnesium metabolism: clinical physiology and diagnostic procedures","author":"Nordin","year":"1976"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1359\/jbmr.1997.12.2.159","article-title":"Cellular and molecular mechanisms of renal phosphate transport","volume":"12","author":"Tenenhouse","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","article-title":"Intestinal phosphate transport","volume":"18","author":"Sabbagh","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.2000.80.4.1373","article-title":"Proximal tubular phosphate reabsorption: molecular mechanisms","volume":"80","author":"Murer","year":"2000","journal-title":"Physiol Rev"},{"issue":"4 Pt 2","key":"10.1016\/j.eprac.2025.07.015_bib5","first-page":"F784","article-title":"Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules","volume":"268","author":"Kempson","year":"1995","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1073\/pnas.95.4.1909","article-title":"Parathyroid hormone leads to the lysosomal degradation of the renal type II Na\/Pi cotransporter","volume":"95","author":"Pfister","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.eprac.2025.07.015_bib7","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1074\/jbc.M200943200","article-title":"Growth-related renal type II Na\/Pi cotransporter","volume":"277","author":"Segawa","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.015_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00424-003-1010-6","article-title":"Cloning, gene structure and dietary regulation of the type-IIc Na\/Pi cotransporter in the mouse kidney","volume":"446","author":"Ohkido","year":"2003","journal-title":"Pflugers Arch"},{"issue":"24","key":"10.1016\/j.eprac.2025.07.015_bib9","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.95.24.14564","article-title":"Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine","volume":"95","author":"Hilfiker","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4214","key":"10.1016\/j.eprac.2025.07.015_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.1188357","article-title":"Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat","volume":"190","author":"Hughes","year":"1975","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1172\/JCI110912","article-title":"Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets","volume":"71","author":"Insogna","year":"1983","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib12","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.015_bib13","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib15","first-page":"722","article-title":"Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia","volume":"118","author":"Yuan","year":"2008","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002708","article-title":"Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice","volume":"8","author":"Wang","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.eprac.2025.07.015_bib18","series-title":"Feldman and Pike\u2019s vitamin D. Volumer 2: Health, Disease and Therapeutics","first-page":"281","article-title":"Clinical disorders of phosphate homeostasis","author":"Liu","year":"2024"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.015_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM198508153130705","article-title":"Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure","volume":"313","author":"Aubier","year":"1985","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0002-9343(88)90065-4","article-title":"Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population","volume":"84","author":"Gravelyn","year":"1988","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.5650050508","article-title":"Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study","volume":"5","author":"Vered","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0016-5085(72)80032-5","article-title":"Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation","volume":"62","author":"Silvis","year":"1972","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp.74.6.820","article-title":"Central pontine myelinolysis temporally related to hypophosphataemia","volume":"74","author":"Michell","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2783","article-title":"1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture, and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.eprac.2025.07.015_bib25","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/SCS.0b013e31819b9868","article-title":"X-linked hypophosphatemic rickets and craniosynostosis","volume":"20","author":"Murthy","year":"2009","journal-title":"J Craniofac Surg"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.015_bib29","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.4443","article-title":"Conductive hearing loss in the Hyp mouse model of X-linked hypophosphatemia is accompanied by hypomineralization of the auditory ossicles","volume":"36","author":"Delsmann","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.015_bib31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.015_bib32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.015_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib34","first-page":"305","article-title":"Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation","volume":"55","author":"Kruse","year":"2001","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib35","first-page":"103","article-title":"[Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family]","volume":"64","author":"Negri","year":"2004","journal-title":"Medicina (B Aires)"},{"issue":"1-2","key":"10.1016\/j.eprac.2025.07.015_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-1119(00)00050-0","article-title":"Molecular cloning of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a candidate autosomal dominant hypophosphatemic rickets (ADHR) gene","volume":"246","author":"White","year":"2000","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.015_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00774-011-0285-5","article-title":"FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets","volume":"30","author":"Sun","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1(-\/-) mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.015_bib40","article-title":"Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion\/insertion mutation in the Enpp1 gene","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.eprac.2025.07.015_bib41","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/s41436-021-01228-4","article-title":"Correspondence on \"Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)\" by Ferreira et al","volume":"23","author":"Stern","year":"2021","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.015_bib42","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jbmr.4315","article-title":"INZ-701 prevents ectopic tissue calcification and restores bone architecture and growth in ENPP1-deficient mice","volume":"36","author":"Cheng","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.3878","article-title":"Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets","volume":"35","author":"Imel","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1 Suppl 1","key":"10.1016\/j.eprac.2025.07.015_bib45","article-title":"McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia","volume":"7","author":"Collins","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","article-title":"The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome","volume":"23","author":"Yamamoto","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.eprac.2025.07.015_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116004","article-title":"Burosumab treatment for fibrous dysplasia","volume":"150","author":"Gladding","year":"2021","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00198-013-2585-1","article-title":"Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases","volume":"25","author":"Ganda","year":"2014","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pediatrneurol.2007.10.012","article-title":"Linear nevus sebaceous syndrome: case reports and review of the literature","volume":"38","author":"Menascu","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"17","key":"10.1016\/j.eprac.2025.07.015_bib52","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib53","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MNM.0000000000001163","article-title":"Performance of 68Ga-DOTA-SST PET\/CT, octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis","volume":"41","author":"Jiang","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"10","key":"10.1016\/j.eprac.2025.07.015_bib55","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.eprac.2025.07.015_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib58","first-page":"135","article-title":"Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders","volume":"134","author":"Chesney","year":"1980","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1995.tb02621.x","article-title":"Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features","volume":"43","author":"Clarke","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.eprac.2025.07.015_bib61","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","article-title":"Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis","volume":"25","author":"Dasgupta","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.015_bib62","first-page":"330","article-title":"Hypo-phosphataemia in children under five years with kwashiorkor and marasmic kwashiorkor","volume":"86","author":"Kimutai","year":"2009","journal-title":"East Afr Med J"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.015_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00774-010-0232-x","article-title":"Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomy","volume":"29","author":"Yamauchi","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.eprac.2025.07.015_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11657-014-0177-0","article-title":"Osteomalacia in Crohn's disease","volume":"9","author":"Dedeoglu","year":"2014","journal-title":"Arch Osteoporos"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.015_bib66","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/oby.2011.133","article-title":"Increased PTH and 1.25(OH)(2)D levels associated with increased markers of bone turnover following bariatric surgery","volume":"19","author":"Sinha","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.015_bib67","first-page":"335","article-title":"[Acute polyneuropathy due to phosphate deficiency during parenteral feeding]","volume":"97","author":"Junge","year":"1979","journal-title":"Fortschr Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.015_bib68","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/dci24-0032","article-title":"Hyperglycemic crises in adults with diabetes: a consensus report","volume":"47","author":"Umpierrez","year":"2024","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib69","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.eprac.2023.08.007","article-title":"A novel risk score to predict hungry bone syndrome after parathyroidectomy for renal hyperparathyroidism","volume":"29","author":"Ramesh","year":"2023","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9343(92)90740-3","article-title":"Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia","volume":"92","author":"Singhal","year":"1992","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib71","first-page":"165","article-title":"Rhabdomyolysis complicating unrecognized hypophosphatemia in an alcoholic patient","volume":"13","author":"Kumar","year":"1999","journal-title":"Can J Gastroenterol"},{"issue":"18","key":"10.1016\/j.eprac.2025.07.015_bib72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","article-title":"Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets","volume":"303","author":"Glorieux","year":"1980","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib73","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI111900","article-title":"Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol","volume":"75","author":"Harrell","year":"1985","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.eprac.2025.07.015_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163259","article-title":"Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia","volume":"8","author":"Rana","year":"2023","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.015_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252348","article-title":"Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH","volume":"16","author":"Yuan","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.015_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ocr.12120","article-title":"A radiological study on intra- and extra-cranial calcifications in adults with X-linked hypophosphatemia and associations with other mineralizing enthesopathies and childhood medical treatment","volume":"19","author":"Gjorup","year":"2016","journal-title":"Orthod Craniofac Res"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.015_bib77","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00198-021-06221-w","article-title":"The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study","volume":"33","author":"Jin","year":"2022","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.015_bib78","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/clinem\/dgaf170","article-title":"X-linked hypophosphatemia management in adults: an international working group clinical practice guideline","volume":"110","author":"Khan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.015_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1487890","article-title":"Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study","volume":"12","author":"Levi","year":"2024","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.015_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/clinem\/dgac518","article-title":"Long-term burosumab administration is safe and effective in adults with X-linked hypophosphatemia","volume":"108","author":"Weber","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.015_bib81","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"10189","key":"10.1016\/j.eprac.2025.07.015_bib82","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.015_bib83","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.015_bib84","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ando.2023.07.108","article-title":"Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia","volume":"84","author":"Zhukouskaya","year":"2023","journal-title":"Ann Endocr"},{"key":"10.1016\/j.eprac.2025.07.015_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1004624","article-title":"Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: a case report","volume":"13","author":"Takashi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.015_bib87","article-title":"Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia","volume":"6","author":"Frumberg","year":"2024","journal-title":"J Pediatr Soc North Am"},{"issue":"9","key":"10.1016\/j.eprac.2025.07.015_bib88","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jbmr.4641","article-title":"Bone matrix mineralization and response to burosumab in adult patients with X-linked hypophosphatemia: results from the phase 3, single-arm international trial","volume":"37","author":"Fratzl-Zelman","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.015_bib89","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib90","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jbmr.4900","article-title":"Burosumab improves patient-reported outcomes in adults with tumor-induced osteomalacia: mixed-methods analysis","volume":"38","author":"Jan de Beur","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"15","key":"10.1016\/j.eprac.2025.07.015_bib91","doi-asserted-by":"crossref","DOI":"10.1242\/dev.163519","article-title":"Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.015_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10672","article-title":"Burosumab and dental abscesses in children with X-linked hypophosphatemia","volume":"6","author":"Gadion","year":"2022","journal-title":"JBMR Plus"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:30:23Z","timestamp":1772890223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1530891X25009735"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.015","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Hypophosphatemic Disorders","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}